Eduardo Mascareno

eduardo-mascareno1

MedHexim1

2014-2015

Affiliations

State University of New York

Technologies

Diagnostic

Therapeutic

Indication

Drug Discovery

Metabolic Disease

Obesity

Executive Summary

View/Download

MedHexim1 focuses on Hexim1 as a biomarker and drug design target as strategy to develop a diagnostic test and therapy for prostate cancer.

Newsletter Signup

Corporate Supporters

Community Service Providers